{"id":"camphotamide","rwe":[{"pmid":"34751244","year":"2021","title":"Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer's Disease.","finding":"","journal":"Frontiers in chemistry","studyType":"Clinical Study"}],"tags":[{"label":"camphotamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tonicorine","offLabel":[],"synonyms":["camphotamide","camphetamide","camphramine","tonicorine"],"timeline":[],"brandName":"Tonicorine","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"camphotamide","explanation":"Imagine your body's cells are like locks, and Tonicorine is a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't know exactly how it does that yet. More research is needed to understand how Tonicorine works and what it does in the body.","oneSentence":"Tonicorine is a small molecule that works by interacting with a specific target in the body, although its exact mechanism of action is unknown.","technicalDetail":"Tonicorine's mechanism of action is currently unknown, and further research is needed to determine its pharmacological properties and potential therapeutic applications."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3699","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=camphotamide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:09:59.235163","biosimilars":[],"competitors":[],"genericName":"camphotamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"724377908B","INN_ID":"17","UMLSCUI":"C2825427","PUBCHEM_CID":"71830"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2021","pmid":"34751244","title":"Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer's Disease.","journal":"Frontiers in chemistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Tonicorine, also known as camphotamide, is a small molecule drug of the camphotamide class. Its target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of Tonicorine is unclear, and it is not known whether it is patented or available as a generic. Further research is needed to determine its safety and efficacy. As a result, Tonicorine is not currently available for clinical use.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}